Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
186
天
Construction of a lung adenocarcinoma overall survival prognostic model based on monocyte-derived macrophage signature genes and exploration of immune crosstalk plus Pan-Cancer prognostic disparities
作者
Yong Zhang; Lanbo Liu; Jie Ma; Shihui Xia展开收起
作者单位
Department of Cardiothoracic Surgery, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, No. 136, Jingzhou Street, Xiangcheng District, 441106 Xiangyang, Hubei, China展开收起
30
天
A novel CD123xVδ2 bispecific T cell engager induces potent and tumor selective Vγ9Vδ2-T cell activity against CD123 expressing acute myeloid leukemia and myelodysplastic syndrome
作者
Jurjen M. Ruben; Charlotte M. Mousset; Dorien van de Berg; Kim Hofman; Milon de Jong; Patricia Brouwer; Sanne Graeve; Victoria Iglesias-Guimarais; Pauline M. van Helden; Anton E.P. Adang; Rob C. Roovers; Hans J. van der Vliet展开收起
作者单位
Department of Medical Oncology, Amsterdam UMC, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, 1081 HV, the Netherlands; LAVA Therapeutics N.V, Utrecht, the Netherlands; Engager BIO B.V, Amstelveen, the Netherlands展开收起
54
天
Genetic and clinical evidence supports HLA-DR+ CD8+ T cells as a favorable immune biomarker in acute myeloid leukemia
作者
Gang Chen; Jing Xu; Xiaoyu He; Yixin Yan; Linhui Hu; Zhenjiang Li展开收起
作者单位
Department of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China展开收起
84
天
Development of bi-functional hybrid IgGA antibodies for enhancing cancer immunotherapy
作者
Xiuyun Li; Vladislav Rybchenko; Naida Mamaeva; Jingyan Wang; Dmitry Dolgikh; Baohang Lin; Victoria Argentova展开收起
作者单位
Faculty of Biology, Shenzhen MSU-BIT University, Shenzhen 518172, China; Department of Thyroid, Breast and Vascular Surgery, Longgang Central Hospital of Shenzhen, Shenzhen 518000, China; Faculty of Biology, Lomonosov Moscow State University, Moscow 119991, Russia; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry (IBKh), Russian Academy of Sciences, Moscow 117997, Russia展开收起
90
天
The relationship between autoantibody and complement levels in the sera of patients with systemic lupus erythematosus
作者
David S. Pisetsky; Yuankang Zhao; Matthew Engelhard; Amanda Eudy; Philip Tedeschi; Tyler O'Malley; Roberta Vezza Alexander; Megan Clowse; Lisa Criscione-Schreiber; Jayanth Doss; Mithu Maheswaranathan; Rebecca Sadun; Kai Sun; Nathaniel Harris; Jennifer Rogers展开收起
作者单位
Duke University School of Medicine, Department of Medicine, Durham, NC, USA; Durham VA Medical Center, Durham, NC, USA; Duke University School of Medicine, Department of Biostatistics & Bioinformatics, Durham, NC, USA; Immunovant, Inc., New York, NY, USA; Exagen, Inc., Vista, CA, USA展开收起
127
天
TIM-3 as a therapeutic target in anaplastic thyroid carcinoma: Preclinical and transcriptomic evidence supporting a new immunotherapy avenue
作者
Monikongkona Boruah; Riyaz Ahmad Mir; Sameer Rastogi; Kapil Sikka; Shipra Agarwal展开收起
作者单位
Department of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, India; Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), New Delhi, India; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India; Department of Otorhinolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences (AIIMS), New Delhi, India展开收起
FAQ
CLINICAL IMMUNOLOGY审稿要多久?
截至2026-11-14,CrushSCI 收录了 CLINICAL IMMUNOLOGY 的 15 篇完整审稿记录。最快一篇从收稿到录用用了 30 天(A novel CD123xVδ2 bispecific T cell engager induces potent and tumor selective Vγ9Vδ2-T cell activity against CD123 expressing acute myeloid leukemia and myelodysplastic syndrome,2026-09-22 收稿,2026-10-22 录用),最慢一篇用了 201 天;平均 97.3 天,中位数 83 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
